10 research outputs found
Recommended from our members
Importation, Antibiotics, and Clostridium difficile Infection in Veteran Long-Term Care: A Multilevel Case-Control Study.
BackgroundAlthough clinical factors affecting a person's susceptibility to Clostridium difficile infection are well-understood, little is known about what drives differences in incidence across long-term care settings.ObjectiveTo obtain a comprehensive picture of individual and regional factors that affect C difficile incidence.DesignMultilevel longitudinal nested case-control study.SettingVeterans Health Administration health care regions, from 2006 through 2012.ParticipantsLong-term care residents.MeasurementsIndividual-level risk factors included age, number of comorbid conditions, and antibiotic exposure. Regional risk factors included importation of cases of acute care C difficile infection per 10 000 resident-days and antibiotic use per 1000 resident-days. The outcome was defined as a positive result on a long-term care C difficile test without a positive result in the prior 8 weeks.Results6012 cases (incidence, 3.7 cases per 10 000 resident-days) were identified in 86 regions. Long-term care C difficile incidence (minimum, 0.6 case per 10 000 resident-days; maximum, 31.0 cases per 10 000 resident-days), antibiotic use (minimum, 61.0 days with therapy per 1000 resident-days; maximum, 370.2 days with therapy per 1000 resident-days), and importation (minimum, 2.9 cases per 10 000 resident-days; maximum, 341.3 cases per 10 000 resident-days) varied substantially across regions. Together, antibiotic use and importation accounted for 75% of the regional variation in C difficile incidence (R2 = 0.75). Multilevel analyses showed that regional factors affected risk together with individual-level exposures (relative risk of regional antibiotic use, 1.36 per doubling [95% CI, 1.15 to 1.60]; relative risk of importation, 1.23 per doubling [CI, 1.14 to 1.33]).LimitationsCase identification was based on laboratory criteria. Admission of residents with recent C difficile infection from non-Veterans Health Administration acute care sources was not considered.ConclusionOnly 25% of the variation in regional C difficile incidence in long-term care remained unexplained after importation from acute care facilities and antibiotic use were accounted for, which suggests that improved infection control and antimicrobial stewardship may help reduce the incidence of C difficile in long-term care settings.Primary funding sourceU.S. Department of Veterans Affairs and Centers for Disease Control and Prevention
Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration.
OBJECTIVE:We identified patients with non-tuberculous mycobacterial (NTM) disease in the US Veterans Health Administration (VHA), examined the distribution of diseases by NTM species, and explored the association between NTM disease and the frequency of clinic visits and mortality. METHODS:We combined mycobacterial isolate (from natural language processing) with ICD-9-CM diagnoses from VHA data between 2008 and 2012 and then applied modified ATS/IDSA guidelines for NTM diagnosis. We performed validation against a reference standard of chart review. Incidence rates were calculated. Two nested case-control studies (matched by age and location) were used to measure the association between NTM disease and each of 1) the frequency of outpatient clinic visits and 2) mortality, both adjusted by chronic obstructive pulmonary disease (COPD), other structural lung diseases, and immunomodulatory factors. RESULTS:NTM cases were identified with a sensitivity of 94%, a specificity of >99%. The incidence of NTM was 12.6/100k patient-years. COPD was present in 68% of pulmonary NTM. NTM incidence was highest in the southeastern US. Extra-pulmonary NTM rates increased during the study period. The incidence rate ratio of clinic visits in the first year after diagnosis was 1.3 [95%CI 1.34-1.35]. NTM patients had a hazard ratio of mortality of 1.4 [95%CI 1.1-1.9] in the 6 months after NTM identification compared to controls and 1.99 [95%CI 1.8-2.3] thereafter. CONCLUSIONS:In VHA, pulmonary NTM disease is commonly associated with COPD, with the highest rates in the southeastern US. After adjustment, NTM patients had more clinic visits and greater mortality compared to matched patients
Incidence rates of NTM cases per 100,000 patient-years receiving care in VA over time.
<p>Incidence rates of NTM cases per 100,000 patient-years receiving care in VA over time.</p
Incident rates of NTM cases per 100,000 patient-years by region and by microbiologically-identified organism from 2009 through 2012.
<p>Reprinted from Esri<sup>®</sup> ArcGIS Online<sup>®</sup> under a CC BY license, with permission from Environmental Systems Research Institute, Inc., original copyright 2017.</p
NTM patient demographics and major co-morbidities, along with age- and setting-matched controls.
<p>NTM patient demographics and major co-morbidities, along with age- and setting-matched controls.</p
Kaplan-Meier curves of survival after pulmonary and extra-pulmonary NTM diagnosis compared to age- and clinical-setting matched controls.
<p>Kaplan-Meier curves of survival after pulmonary and extra-pulmonary NTM diagnosis compared to age- and clinical-setting matched controls.</p
Mycobacterial categories found in microbiology and laboratory data in VHA.
<p>Mycobacterial categories found in microbiology and laboratory data in VHA.</p
United States Veterans Health System regions grouped by first three digits of zip code.
<p>Incidence rates area denominated by 100,000 patient-years. Moran’s I measures the spatial correlation of a region with adjacent regions; positive correlations are >1, while negative correlations are <1. Reprinted from Esri<sup>®</sup> ArcGIS Online<sup>®</sup> under a CC BY license, with permission from Environmental Systems Research Institute, Inc., original copyright 2017.</p
Multivariable models of outpatient clinic visit rates and mortality.
<p>Mortality is split into early and late periods in piecewise models.</p
Taking an Antibiotic Time-out: Utilization and Usability of a Self-Stewardship Time-out Program for Renewal of Vancomycin and Piperacillin-Tazobactam.
BackgroundAntibiotic time-outs can promote critical thinking and greater attention to reviewing indications for continuation.ObjectiveWe pilot tested an antibiotic time-out program at a tertiary care teaching hospital where vancomycin and piperacillin-tazobactam continuation past day 3 had previously required infectious diseases service approval.MethodsThe time-out program consisted of 3 components: (1) an electronic antimicrobial dashboard that aggregated infection-relevant clinical data; (2) a templated note in the electronic medical record that included a structured review of antibiotic indications and that provided automatic approval of continuation of therapy when indicated; and (3) an educational and social marketing campaign.ResultsIn the first 6 months of program implementation, vancomycin was discontinued by day 5 in 93/145 (64%) courses where a time-out was performed on day 4 versus in 96/199 (48%) 1 year prior (P = .04). Seven vancomycin continuations via template (5% of time-outs) were guideline-discordant by retrospective chart review versus none 1 year prior (P = .002). Piperacillin-tazobactam was discontinued by day 5 in 70/105 (67%) courses versus 58/93 (62%) 1 year prior (P = .55); 9 continuations (9% of time-outs) were guideline-discordant versus two 1 year prior (P = .06). A usability survey completed by 32 physicians demonstrated modest satisfaction with the overall program, antimicrobial dashboard, and renewal templates.ConclusionsBy providing practitioners with clinical informatics support and guidance, the intervention increased provider confidence in making decisions to de-escalate antimicrobial therapy in ambiguous circumstances wherein they previously sought authorization for continuation from an antimicrobial steward